New 4-maleamic acid and 4-maleamide peptidyl chalcones as potential multitarget drugs for human prostate cancer.
Rodrigues J, Abramjuk C, Vásquez L, Gamboa N, Domínguez J, Nitzsche B, Höpfner M, Georgieva R, Bäumler H, Stephan C, Jung K, Lein M, Rabien A.
Rodrigues J, et al. Among authors: nitzsche b.
Pharm Res. 2011 Apr;28(4):907-19. doi: 10.1007/s11095-010-0347-8. Epub 2010 Dec 24.
Pharm Res. 2011.
PMID: 21184149